Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

recurrent esophageal cancer

Known as: esophageal cancer, recurrent, Recurrent Cancer of the Esophagus, Relapsed Carcinoma of the Esophagus 
An esophageal carcinoma which has reappeared after a period of remission or after presumed treatment.
National Institutes of Health

Related topics

Related topics

9 relations
Epithelial CellsEpitheliumEpithelium of esophagusEsophagus
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
Purpose: Preparative lymphodepletion, the temporal ablation of the immune system, has been reported to promote persistence of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
BackgroundStrategies for the treatment of recurrence after initial curative esophagectomy are increasingly being recognized. The… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Review
2015
Review
2015
Diagnostic Performance of 18F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis
The aim of this study was to assess the diagnostic performance of 18F-FDG PET and integrated 18F-FDG PET/CT for diagnosing… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Highly Cited
2010
Highly Cited
2010
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy
PurposeTo evaluate the efficacy and safety of weekly paclitaxel (Taxol®) in patients with advanced or recurrent esophageal cancer… Expand
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
2006
Highly Cited
2006
Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
BACKGROUND Self-expanding metallic stents (SEMS) are a first-line therapeutic procedure in the palliative treatment of dysphagia… Expand
Highly Cited
2003
Highly Cited
2003
Morbidity and mortality after self-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy.
BACKGROUND Placemet of self-expandable metallic stents in patients with advance esophageal cancer improves dysphagia and occludes… Expand
Review
2002
Review
2002
Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
PURPOSE The aim was to assess the improvement in swallowing status, complication rate, and overall survival. PATIENTS AND… Expand
Highly Cited
2000
Highly Cited
2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
OBJECTIVE To study the utility of whole-body positron emission tomography with (18)F-fluoro-deoxy-D -glucose (FDG-PET) for the… Expand
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
2000
2000
Esophageal Cancer with Distant Lymph Node Metastasis: Prognostic Significance of Metastatic Lymph Node Ratio
The cervical and celiac lymph node metastases are defined as distant metastasis (Mlym) from thoracic esophageal carcinoma by TNM… Expand
Highly Cited
1996
Highly Cited
1996
Management of malignant esophagotracheal fistulas with airway stenting and double stenting.
Prognosis of inoperable or recurrent esophageal carcinoma is, at best, poor. Once an esophagotracheal fistula has developed, the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE